Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Akiko Kishioka is active.

Publication


Featured researches published by Akiko Kishioka.


Journal of Dermatology | 2006

Effects of alpha-hydroxy acids on the human skin of Japanese subjects: The rationale for chemical peeling

Yuki Yamamoto; Koji Uede; Nozomi Yonei; Akiko Kishioka; Toshio Ohtani; Fukumi Furukawa

Alpha‐hydroxy acid (AHA) agents, such as glycolic acid and lactic acid, have been used as therapeutic agents for more than a quarter of a century. Recently, they have been used as agents to rejuvenate photo‐aged skin. It is believed that these AHA agents induce the epidermis to remodel and accelerate desquamation, thus exerting their therapeutic effects. In this study, we investigated the histological differences in skin treated with glycolic, lactic, citric and acetic acids once daily for 6 weeks. The melanin pigments in the basal layer were less prominent in the glycolic and lactic acid‐treated skin than in the citric and acetic acid‐treated skin. The melanin deposits in the horny layers were equal for all AHA. However, the melanin deposits in the squamous layers were less prominent in the glycolic and lactic acid‐treated skins than in the citric and acetic acid‐treated skins; this was analogous to observations of the basal layers. Collagen I and procollagen I were increased after treatment with glycolic, lactic and citric acid in the upper dermis, but were not increased with acetic acid treatment. However, the staining of the epidermis and dermis for matrix metalloproteinase‐1 (MMP‐1) after treatment was not significantly different among the agents. Our data suggest that longer treatment intervals with glycolic and lactic acid can cause improvements in both the epidermal and dermal components and support the usefulness of AHA for rejuvenating photo‐damaged skin.


Journal of The American Academy of Dermatology | 2009

Phenol peels as a novel therapeutic approach for actinic keratosis and Bowen disease: Prospective pilot trial with assessment of clinical, histologic, and immunohistochemical correlations

Chikako Kaminaka; Yuki Yamamoto; Nozomi Yonei; Akiko Kishioka; Toshikazu Kondo; Fukumi Furukawa

BACKGROUND Although chemical peels may be used for precancerous lesions, no histologic or immunohistochemical studies have been performed to validate clinical impressions and/or outcome. OBJECTIVE Our purpose was to investigate the efficacy and prognostic relevance of phenol peels in Japanese patients with actinic keratosis and Bowen disease using clinical and histologic criteria. METHODS A total of 46 patients were treated with phenol peels, and followed up for at least 1 year after treatment. Biopsy specimens were taken before and after treatment. Cases of complete response were classified by the number of treatment sessions. We evaluated parameters for epidermal thickness, proliferation, dysplasia, and apoptosis, and clinical characteristics to correlate phenol peels with assessments of efficacy, patient-selection criteria, and risk for transformation to cutaneous squamous cell carcinoma. RESULTS There were 39 (84.8%) patients with a complete response after one to 8 treatment sessions. Statistically, differences in clinical improvement with peels and the number of treatment sessions correlated with histology, personal history of skin cancer, tumor thickness, and cyclin A expression. LIMITATIONS This study was a prospective pilot trial. Blinded, placebo-controlled, randomized studies would be ideal. CONCLUSION We conclude that phenol peels are very effective for treating precancerous lesions of actinic keratosis and Bowen disease. In addition, our study clearly demonstrates that tumor thickness and cyclin A could be specific and useful markers as adjunctive diagnostic tools to predict the efficacy of phenol treatment of these lesions.


European Journal of Dermatology | 2009

Effective treatment of intractable skin ulcers using allogeneic cultured dermal substitutes in patients with systemic lupus erythematosus

Seiko Toyozawa; Yuki Yamamoto; Akiko Kishioka; Nozomi Yonei; Nobuo Kanazawa; Yasuhiro Matsumoto; Yoshimitsu Kuroyanagi; Fukumi Furukawa

Skin ulcers in systemic lupus erythematosus (SLE) patients are non-healing or intractable, because various factors or complications, including vasculitis and immunosuppressants, impair wound healing. In the present study, we applied cultured dermal substitutes (CDSs) to 3 cases of SLE skin ulcers because various systemic or topical therapies were ineffective. CDSs are prepared by culturing human fibroblasts on two-layered spongy matrices of hyaluronic acid and atelo-collagen, and they effectively promote the healing of severe skin defects. After using CDSs in the 3 cases, healthy granulation tissues formed within 6 weeks, and skin grafts were successfully performed. These results indicate that allogeneic CDSs provide new therapeutic alternatives as topical therapies for intractable skin ulcers in SLE.


Journal of Dermatology | 2010

Successful treatment with trichloroacetic acid peeling for inflammatory linear verrucous epidermal nevus

Seiko Toyozawa; Yuki Yamamoto; Chikako Kaminaka; Akiko Kishioka; Nozomi Yonei; Fukumi Furukawa

Figure 1. Histology showing hyperkeratosis of orthotype and parakeratosis (hematoxylin–eosin, original magnification ·100). Dear Editor, Inflammatory linear verrucous epidermal nevus (ILVEN) was originally reported by Altman and Mehregan in 1971. The following criteria seem to be valid: (i) early age of onset; (ii) pruritic erythematous, slightly verrucous scaling papules, which coalesce into linear plaques; (iii) histological features resembling those of psoriasis; and (iv) persistent lesions markedly refractory to treatment. The criterion of ‘‘resistance to therapy’’ is a generally accepted feature of this nevus. Here, we report a patient whose lesions responded effectively to trichloroacetic acid (TCA) peeling treatment. Our patient was a 5-year-old girl. At the age of 1 year, her mother noticed verrucous scaling papules, which coalesced into linear plaques on her right armpit, right pubic region, left breast and left lower leg. These lesions spread gradually, and topical corticosteroids were ineffective. Histological findings from the lesion on the left lower leg showed acanthosis, with elongation of the rete ridges. There were areas with hyperkeratosis of the orthotype, and areas with parakeratosis. The upper dermis showed a mild and predominantly mononuclear infiltrate. Polymorphonuclear leukocytes were sparse, and no exocytosis of these cells into the epidermis was seen (Fig. 1). Initial treatment was topical corticosteroids, vitamin D3 and liquid nitrogen, but they were not effective; therefore, these skin lesions fulfilled the criteria for a diagnosis of ILVEN. After several treatments, we started to treat the lesions with TCA peeling (Fig. 2a). First, we carefully cleaned the skin using 70% ethanol and acetone-soaked gauze to remove any sebum from the application sites. Second, 70% glycolic acid was applied to the site with intensive hyperkeratosis. Next, we applied 60% TCA (w ⁄v) (Wako Pure Chemical Industries, Osaka, Japan) in distilled water to the region using cotton-tipped applicators until white


European Journal of Dermatology | 2015

A rare case of mucinous carcinoma of the skin with multiple organ metastases

Atsushi Tanemura; Ayaka Deguchi; Aya Tanaka; Eiji Kiyohara; Akiko Kishioka; Ichiro Katayama

Mucinous carcinoma of the skin (MCS), which was first reported by Lennox [1], is an adnexal neoplasm considered to originate from the secretory coil of eccrine sweat glands [2]. It is a rare skin malignancy as only approximately 200 cases have so far been reported [3]. Its most common location is the head and neck [4]. Although local recurrences are frequent, only a few cases of distant metastases have been so far reported [5, 6]. We present herein an extremely rare case of MCS metastasizing to [...]


Journal of Dermatological Science Supplement | 2006

Different apoptotic patterns observed in tissues damaged by phenol and TCA peels

Yuki Yamamoto; Koji Uede; Toshio Ohtani; Akiko Kishioka; Toshiko Tanaka; Fukumi Furukawa


Dermatology Online Journal | 2008

Case report: a case of pyoderma gangrenosum with intractable leg ulcers treated by allogeneic cultured dermal substitutes.

Seiko Toyozawa; Yuki Yamamoto; Takeshi Nishide; Akiko Kishioka; Nobuo Kanazawa; Yasuhiro Matsumoto; Yoshimitsu Kuroyanagi; Fukumi Furukawa


Journal of Dermatological Science | 2004

Effects of phenol peeling on dermal endothelial cells

Yuki Yamamoto; Nozomi Yonei; Chikako Kaminaka; Akiko Kishioka; Koji Uede; Fukumi Furukawa


Archive | 2007

Efficacy of suplatast tosilate for treatment of atopic dermatitis poorly controlled by other anti-allergic drugs

Yumi Matsumura; Yoshiki Miyachi; Yoshinari Matsumoto; Shun Kitaba; Ichiro Katayama; Akiko Kishioka; Fukumi Furukawa; Yasuo Kubota; Gen Nakanishi; Keiji Iwatsuki; Sakae Kaneko; Eishin Morita; Kunio Izu; Yoshiki Tokura; Shuji Fukagawa; Masutaka Furue; Motoi Takenaka; Shinichi Sato; Kazumoto Katagiri


Journal of the society of cosmetic chemists | 2007

Evaluation of Effects of Hydroquinone on Pigmentation by Spectroscopy Image Analysis

Masahiko Ohe; Madoka Inui; Akiko Kishioka; Nozomi Yonei; Yuki Yamamoto; Fukumi Furukawa

Collaboration


Dive into the Akiko Kishioka's collaboration.

Top Co-Authors

Avatar

Fukumi Furukawa

Wakayama Medical University

View shared research outputs
Top Co-Authors

Avatar

Yuki Yamamoto

Wakayama Medical University

View shared research outputs
Top Co-Authors

Avatar

Nozomi Yonei

Wakayama Medical University

View shared research outputs
Top Co-Authors

Avatar

Chikako Kaminaka

Wakayama Medical University

View shared research outputs
Top Co-Authors

Avatar

Koji Uede

Wakayama Medical University

View shared research outputs
Top Co-Authors

Avatar

Seiko Toyozawa

Wakayama Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nobuo Kanazawa

Wakayama Medical University

View shared research outputs
Top Co-Authors

Avatar

Toshio Ohtani

Wakayama Medical University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge